Knowledge, Attitudes and Practices of Health Care Practitioners regarding Crushing or Splitting Oral Solid Dosage Forms in Benghazi Medical Centre, Libya.
Abstract
Background: Crushing or splitting oral solid dosage forms is a widespread practice among health care professionals for many reasons such as swallowing difficulty or dose adjustment. However, this practice may alter drug properties in ways that can result in increased toxicity or instability.
Aim of study: This study was conducted to investigate and compare the knowledge, attitudes and practices of health care practitioners toward crushing or splitting oral solid dosage forms in Benghazi Medical Centre.
Method: A cross-sectional study employing a self-administered questionnaire was conducted during March and April 2019 among health care professionals whom working in Benghazi Medical Centre. The data was analyzed using the Statistical Package for Social Sciences.
Results and discussions: This study demonstrated that around 35.6% of the participants believed that all types of oral solid medications can be split or crushed. Interestingly, 41.9% thought that this practice does not cause dangerous problems to patients, and 24% agreed that it is allowed to crush or split Omeprazole enteric coated capsule. Moreover, 32% said that it is allowed to crush or split Carbamazepine controlled release tablets. However, Omeprazole is inactivated by acid in the stomach if it is crushed, whereas Carbamazepine is a narrow therapeutic index drug and its crushing may lead to toxicity. Overall, there was a significant difference among the participants̕ knowledge, attitudes and practices regarding crushing or splitting oral solid dosages (p value= 0.00001).
Conclusion: This study concluded that there was a lack of awareness among health care professionals toward special formulations that should not be split or crushed. The knowledge, attitudes and practices toward crushing and splitting oral solid dosages was the poorest among nurses and the best among pharmacists. Pharmacists can play a major role in educating nurses and identifying situations where crushing maybe unnecessary and suggest appropriate alternatives. Therefore, educational programs, training and collaboration between them could improve this practice.
References
[2]. World Health Organization. The pursuit of responsible use of medicines. Ginebra, Suiza: WHO Press, 2012. Available from: http://apps.who.int/iris/bitstream/10665/75828/1/WHO EMPMAR 2012.3 eng.pdf?ua=1 [ Last accessed 18/9/2019 ].
[3]. Strachan, I., Greener, M. Medication-related swallowing difficulties may be more common than we realise. Pharmacy Practice, 2005. 15: p. 411–414.
[4]. Mafiana, R. N., Taqi, A., Al-Zakwani, I. Evaluation of nurses’ knowledge of oral solid dosage forms that should not be crushed at a university hospital in Oman. Journal of Pharmaceutical Health Services Research, 2014. 5: p. 49-53.
[5]. Nissen, L., Haywood, A., Steadman, K. Solid medication dosage form modification at the bedside and in the pharmacy of Queensland hospitals. Journal of pharmacy practice and research, 2009. 39(2): p. 129–134.
[6]. Griffith, R., Davies, R. Tablet crushing and the law: the implications for nursing. Professional Nurse, 2003. 19: p. 41–42.
[7]. Abdallah, Y. M. Attitudes, knowledge and practices of health care practitioners toward splitting or crushing oral solid dosage forms in Palestine: safety and therapeutic implications. A thesis is submitted in partial fulfillment of the requirements for the degree of master of clinical pharmacy. 2015, Palestine: An-Najah National University.
[8]. Bachynsky, J., Wiens, C., Melnychuk, K. The practice of splitting tablets: Cost and therapeutic aspects. Pharmacoeconomics, 2002. 20(5): p. 339-346.
[9]. Cornish, P. ‘Avoid the crush: hazards of medication administration in patients with dysphagia. Canadian Medical Association Journal, 2005. 172 (7): p. 871–872.
[10]. Noviasky, J., Lo, V., Luft, D. D. Which medications can be split without compromising efficacy and safety?. Journal of Family Practice, 2006. 55: p. 707-8.
[11]. Barton, R.G., Caran-Graves, R. D. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hospital Pharmacy, 2004. 39: p. 225–237.
[12]. Mercovich, N., Kyle, G J., Naunton, M. Safe to crush? A pilot study into solid dosage form modification in aged care. Australasian Journal on Ageing, 2013.12037.
[13]. Kelly, J., D'Cruz, G.,Wright, D. A qualitative study of the problems surrounding medicine administration to patients with dysphagia. Dysphagia, 2009. 24: p. 49–56.
[14]. Aulton, M. E. Pharmaceutics: the design and manufacture of medicines. 4th ed., Edinburgh; New York: Churchill Livingstone, 2013.
[15]. Stubbs, J., Haw, C., Dickens, G. Dose form modification–a common but potentially hazardous practice:A literature review and study of medication administration to older psychiatric inpatients. International Psychogeriatrics, 2008. 20: p. 616–627.
[16]. Hider, J. D., Shehab, Z., Courteney-Harris, R. Drug points: effectiveness of modified release isosorbide mononitrate affected by incorrect use. Br Med Journal, 2000. 320: p. 483.
[17]. Schier, J.G., Howland, M. A., Hoffman, R. S. Fatality from administration of labetalol and
crushed extended-release nifedipine. Annals of Pharmacotherapy,2003. 37: p. 1420–1423.
[18]. Abdallah, S., Al-Abduwahed, N. Availability and Stability of Crushed Warfarin Tablet in Different Solvents. The pharmaceutical and chemical journal, 2016. 3(2): p. 316-322.
19. Sultan A, Ali A, Abdulmalik A, Raed A,Tarek M, Emad M . Kidney cancer in Saudi Arabia, Saudi Med J 2018; 39 (5): 459–463.
20. Ingimarsson JP, Sigurdsson MI, Hardarson S, et al. The impact of tumour size on the probability of synchronous metastasis and survival in renal cell carcinoma patients: a population-based study [published correction appears in BMC Urol. 2015; 15:5]. BMC Urol. 2014; 14:72.
21. di Martino, S., De Luca, G., Grassi, L. et al. Renal cancer: new models and approach for personalizing therapy. J Exp Clin Cancer Res, 2018; 37 :217.
